| Transforming Interventional Neuroradiology | Contour Neurovascular System | NEQSTENT | Intra-saccular flow diversion Cerus | Cerus Endovascular |
Employees: 11-50
Total raised: $2.33M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Mid Atlant... | bioangels.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.06.2013 | - | $2.33M | The North ... |
Mentions in press and media 3
| Date | Title | Description |
| 09.05.2023 | MABA Portfolio Company Cerus Endovascular Acquired by Stryker | Cerus was one of MABA’s earliest investments. We are thrilled to have played a role in its ultimate success.” — Yaniv SneorNEW YORK CITY, NY, USA, May 9, 2023/EINPresswire.com/ -- Mid Atlantic Bio Angels (MABA), a NY-based life science ange... |
| 28.08.2019 | Cerus Endovascular tops $5m funding goal, raises target to $20m | Cerus Endovascular raised its fundraising goal to $20 million this week after it pushed past its previous $5 million target by about $900,000, according to a regulatory filing. The Oxford, U.K.-based company is developing the Contour neurov... |
| 06.06.2013 | Cerus Endovascular Raises £1.5M in Funding | Cerus Endovascular Ltd, an Oxford, UK-based developer of a minimally invasive implantable medical device for treating intracranial aneurysms, raised £1.5m in funding. Among the others, backers included New York City-based Mid Atlantic Bio A... |